The IMF Online Myeloma Community Workshop will include an introduction to myeloma, upfront treatments at diagnosis, maintenance therapy, relapse information, and an update on clinical trials. A member of the IMF Nurse Leadership Board will talk about managing side effects and symptoms of myeloma and its treatments. After each presentation with the experts, attendees will have ample time to ask questions.

Myeloma 101 and Frontline Therapy

Joseph Mikhael, MD, MEd, FRCPC, FACP reviews multiple myeloma basics including what myeloma is, common symptoms and side effects, advances in how myeloma is initially diagnosed, the stages of myeloma treatment, induction therapy, transplant, and more. 

Relapsed Therapy and Clinical Trials

Louis Williams, MD, MBA discusses the types of relapsed disease, what doctors consider when selecting a treatment regimen, relapsed/refractory treatment options, how doctors treat triple and penta-class refractory myeloma, updates on clinical trials, and more. 

Life is a Canvas, You are the Artist

Beth Faiman, PhD, RN, MSN, APRN-BC, AOCN®, FAAN, FAPO (IMF Nurse Leadership Board) discusses how patients can manage myeloma-related symptoms and side effects along with side effects brought on by treatment. She outlines the most common side effects for each myeloma drug category, how to prevent infection, and more.

Additional Resources:

Download the IMF's Multiple Myeloma Informational Booklets:

Download IMF publications (https://www.myeloma.org/cancer-information-series)

Workshop Sponsors:

With Support From: Abbvie, Amgen, Bristol Myers Squibb, GSK, Johnson & Johnson, Karyopharm, Sanofi and Takeda Oncology

(The IMF is not responsible for content provided by the links below and you may be subject to the Privacy Policy and Terms & Conditions of the destination site(s).)

	Cervino Study (https://cervinostudy.com/home/) CERVINO patient brochure (https://imf-d8-prod.s3.us-west-1.wasabisys.com/2024-11/Abbvie-cervino-study.pdf) CLINICAL TRIAL FACT SHEET - Etentamig (ABBV-383) (https://imf-d8-prod.s3.us-west-1.wasabisys.com/2024-11/CTFS_ABBV-383_NCT06158841_a5_single.pdf) CLINICAL TRIAL FACT SHEET - Etentamig (ABBV-383) Espanol (https://imf-d8-prod.s3.us-west-1.wasabisys.com/2024-11/CTFS_ABBV-383_NCT06158841_ES_a5-02_single.pdf)
	Even the Odds (https://imf-d8-prod.s3.us-west-1.wasabisys.com/2021-04/AMGEN-Even-the-Odds.pdf)
	Revlimid Treatment Overview brochure (https://media.revlimid.com/wp-content/uploads/2020/01/US-REV-19-0673-REVLIMID-Treatment-Overview-Brochure.pdf) POM My Disease and Treatment (pomalyst.com) (https://www.pomalyst.com/assets/commercial/us/pomalystdtc/en/pdf/POM-My-Disease-and-Treatment-2204-US-2100028.pdf) Harness your power to fight MM with ABECMA® (https://imf-d8-prod.s3.us-west-1.wasabisys.com/2021-06/BMS%20for%20Table%20Top%20-%20Abecma%20Patient%20Brochure.pdf)
	KaryForward, Patient Support Program (https://www.karyforward.com/assets/pdf/English_KF_Patient_Flyer_Sept2021.pdf) KaryForward, Patient Support Program, Espanol (https://www.karyforward.com/assets/pdf/Spanish_KF_Patient_Flyer_Feb2022_final.pdf) Patient and Caregiver Brochure (https://www.xpovio.com/content/pdf/mm/XPOVIO_Patient_and_Caregiver_Brochure.pdf) Treatment Experience Guide (https://www.xpovio.com/content/pdf/mm/Patient-Treatment-Experience-3.23.pdf)
	SARCLISA® (isatuximab-irfc) | A Targeted Immunotherapy (https://www.sarclisa.com/) CareASSIST: Helping eligible patients access their prescribed medications, CareASSIST for Sanofi medications | Patient Site (sanoficareassist.com) (https://www.sanoficareassist.com/)
	Multiple Myeloma Relapse Guide - NINLARO® (ixazomib) (https://www.ninlaro.com/sites/default/files/resources/ninlaro-patient-relapse-brochure.pdf) Understanding your Multiple Myeloma Lab Tests (ninlaro.com) (https://www.ninlaro.com/sites/default/files/2022-12/understanding_multiple_myeloma_lab_tests.pdf) Working with Your Care Team (ninlaro.com) (https://www.ninlaro.com/sites/default/files/2022-12/ninlaro_patient-_conversation_starter.pdf)